Q1 Earnings Estimate for CGEM Issued By Leerink Partnrs
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) – Equities researchers at Leerink Partnrs raised their Q1 2025 EPS estimates for Cullinan Therapeutics in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now expects that the company will earn ($0.77) per share for the quarter, up from their previous […]
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) – Equities researchers at Leerink Partnrs raised their Q1 2025 EPS estimates for Cullinan Therapeutics in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now expects that the company will earn ($0.77) per share for the quarter, up from their previous […]
